Skip to main content
. 2020 Sep 4;9:92. Originally published 2020 Feb 7. [Version 2] doi: 10.12688/f1000research.21299.2

Table 4. Multidrug resistance (MDR) Campylobacter spp. isolates profile by antimicrobial sensitivity testing.

Drug (dose) profiles No of MDR resistant isolates
per species		 MDR Camylobacter
spp. isolates (n=68)
C. jejuni
(n=30)		 C. coli
(n=27)		 C. lari
(n=11)
1. Ciprofloxacin (5 mg), nalidixic acid (30 mg),
tetracycline (30 mg), erythromycin (15mg)		 25 23 9 57 (84%)
2. Nalidixic acid (30 mg), tetracycline (30 mg),
erythromycin (15 mg)		 1 3 1 5 (7.3%)
3. Ciprofloxacin (5 mg), erythromycin (15mg) 5 4 2 11 (16%)
4. Tetracycline (30 mg), erythromycin (15 mg) 0 1 0 1 (1.5%)